Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia ; volume:22 ; number:1 ; day:9 ; month:8 ; year:2023 ; pages:1-13 ; date:12.2023
Malaria journal ; 22, Heft 1 (9.8.2023), 1-13, 12.2023
- Urheber
-
Rahmasari, Farindira Vesti
Asih, Puji Budi Setia
Rozi, Ismail Ekoprayitno
Wangsamuda, Suradi
Risandi, Rifqi
Dewayanti, Farahana Kresno
Permana, Dendi Hadi
Syahrani, Lepa
Prameswari, Helen Dewi
Basri, Herdiana H.
Bustos, Maria Dorina G.
Charunwatthana, Prakaykaew
Dondorp, Arjen M.
Imwong, Mallika
Syafruddin, Din
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12936-023-04658-4
- URN
-
urn:nbn:de:101:1-2023110209055940662934
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rahmasari, Farindira Vesti
- Asih, Puji Budi Setia
- Rozi, Ismail Ekoprayitno
- Wangsamuda, Suradi
- Risandi, Rifqi
- Dewayanti, Farahana Kresno
- Permana, Dendi Hadi
- Syahrani, Lepa
- Prameswari, Helen Dewi
- Basri, Herdiana H.
- Bustos, Maria Dorina G.
- Charunwatthana, Prakaykaew
- Dondorp, Arjen M.
- Imwong, Mallika
- Syafruddin, Din
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine
Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Brugada syndrome precipitated by uncomplicated malaria treated with dihydroartemisinin piperaquine: a case report
Budget Impact Analysis of Using Dihydroartemisinin–Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia
What’s wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries?
Decision-making in the detection and management of patients with sepsis in resource-limited settings: the importance of clinical examination
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine
Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Brugada syndrome precipitated by uncomplicated malaria treated with dihydroartemisinin piperaquine: a case report
Budget Impact Analysis of Using Dihydroartemisinin–Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia
What’s wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries?
Decision-making in the detection and management of patients with sepsis in resource-limited settings: the importance of clinical examination
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine
Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Brugada syndrome precipitated by uncomplicated malaria treated with dihydroartemisinin piperaquine: a case report
Budget Impact Analysis of Using Dihydroartemisinin–Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia
What’s wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries?